Alder Biopharm (ALDR) PT Lowered to $20 at RBC Capital Aug 7, 2019 06:47AM
Alder BioPharmaceuticals® to Present at Two Upcoming May Investor Conferences May 14, 2019 04:05PM
Alder BioPharmaceuticals® to Present at Two Upcoming May Investor Conferences May 14, 2019 04:05PM
Alder Biopharm (ALDR) PT Lowered to $21 at RBC Capital May 2, 2019 06:46AM
Alder BioPharmaceuticals, Inc. Announces Closing of Public Offering and Private Placement of Common Stock and Exercise in Full of Option to Purchase Additional Shares Mar 4, 2019 06:48PM


Mar 4, 2019 06:48PM Alder BioPharmaceuticals, Inc. Announces Closing of Public Offering and Private Placement of Common Stock and Exercise in Full of Option to Purchase Additional Shares
Feb 28, 2019 05:55AM Alder BioPharma (ALDR) Prices 11.3M Share Common Offering at $11.50/Sh
Feb 27, 2019 08:07PM Alder BioPharmaceuticals, Inc. Prices Public Offering of Common Stock
Feb 27, 2019 08:07PM Alder BioPharmaceuticals, Inc. Prices Public Offering of Common Stock
Feb 26, 2019 04:02PM Alder BioPharma (ALDR) to Offer Up to $105M in Common Stock and Concurrent Private Placement
Feb 26, 2019 04:01PM Alder BioPharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
Feb 26, 2019 04:01PM Alder BioPharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
Feb 26, 2019 06:26AM Alder Biopharm (ALDR) PT Lowered to $25 at RBC Capital
Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC
Aug 8, 2018 08:09AM Alder Biopharm (ALDR) PT Raised to $27 at RBC Capital; 'All On Track For 1Q19 Epti BLA Filing'
May 31, 2018 03:56PM RBC Positive on Biogen (BIIB) Karp Hire Amid Partnerships/M&A Potential
May 31, 2018 01:42PM RBC Sees Positive Read-Through to Alder Biopharm (ALDR) from Allergan, Biogen Developments
May 15, 2018 08:13AM Alder BioPharma (ALDR) Has Positive Read-Through from Eli Lilly's Cluster Headache Data - RBC
May 9, 2018 08:12AM Alder Biopharm (ALDR) PT Lowered to $24 at RBC Capital
Apr 18, 2018 01:59PM Biogen (BIIB) Missed Out on AveXis (AVXS) But Well-Positioned for Substantial Acquisition - RBC
Feb 8, 2018 08:00AM Alder BioPharmaceuticals® to Present at Two Upcoming February Investor Conferences
Feb 8, 2018 08:00AM Alder BioPharmaceuticals® to Present at Two Upcoming February Investor Conferences
Sep 15, 2017 02:17AM RBC Capital Starts Alder Biopharm (ALDR) at Outperform
Jun 24, 2015 10:30AM Notable Analyst Rating Changes 6/24: (RCL) (EA) (MRGE) Upgraded; (C) (GM) (FTNT) Downgraded